Weekly Executive & Director Moves (Sep 22)

by | Sep 22, 2023

Boardroom Alpha provides in-depth analytics and tracking of all public company executives and officers. Below is a rundown of people moves made at notable companies this past week. Get a demo today to see how you can receive real-time alerts and in-depth analytics.

Moves in this Issue

CEO

BDTX, CBOE, CENT, DHI, EBC, FFIE, PLNT, TIO

CFO

ALTI, BCEL, BHC, BRCC, DDD, IMGN, MODV, NVRI, NVST, ONDS, PRPL, REPL, SMBC, UAL, WMG

Directors

ADNT, AGBA, ATRI, AUPH, AZEK, BARK, BNED, CBOE, CBT, CDLX, CLNE, CLNN, CMPS, COHR, COSM, CPRX, DKS, DMS, FDX, FFIE, FIVE, FLS, FLYW, GLPI, GTBIF, INSG, JWN, L, LANC, LEN, MCOM, MMAT, MOND, NWBI, NWL, NWSA, ONDS, PEG, PINS, PM, PRTK, QSI, RADI, SNAP, SPWH, SR, STLD, STOK, TDOC, TIO, UGI, UP, VLY, WU, XNCR

CEO MOVES

BLACK DIAMOND THERAPEUTICS INC (BDTX)
Leaving: CEO – David M Epstein ( 7.0 yrs; -48.3% TSR)
Replaced by: Mark A Velleca

Mark A. Velleca, M.D., Ph.D. has been our chair since December 2022 and a member of our board of directors since August 2021. Dr. Velleca is currently the Chief Executive Officer of StrideBio, Inc., a gene therapy company. Dr. Velleca also currently serves as a Senior Advisor to and a member of the board of directors of G1 Therapeutics, Inc., or G1 Therapeutics, a publicly-traded commercial stage …read full bio

CBOE GLOBAL MARKETS INC (CBOE)
Leaving: CEO – Edward T Tilly ( 10.3 yrs; 16.3% TSR)
Replaced by: Fredric J Tomczyk

Fredric J. Tomczyk Independent Age: 67 Committees: Compensation Finance and Strategy Background Mr. Tomczyk has served on our Board since July 2019. He is the retired President and Chief Executive Officer of TD Ameritrade Holding Corporation, a position he held from October 2008 to October 2016. Prior to this position, he held positions of increasing responsibility and leadership with the TD organ…read full bio

CENTRAL GARDEN & PET CO (CENT)
Leaving: CEO – Timothy P Cofer ( 4.0 yrs; 12.2% TSR)
Replaced by: Mary Beth Springer

Ms. Springer, age 59, has served as the Company’s lead independent director since October 2020. From 2009 to 2011, Ms. Springer served as Executive Vice President and General Manager of The Clorox Company. She served as Clorox’s Group Vice President – Strategy and Growth from 2007 until 2009. She was Group Vice President and General Manager, Specialty Division from 2005 to 2007 and Vice President …read full bio

FARADAY FUTURE INTELLIGENT ELECTRIC INC (FFIE)
Leaving: CEO – Xuefeng (“XF”) Chen ( .8 yrs; -84.5% TSR)
Replaced by: Matthias Aydt

Mr. Aydt, age 66, has served as the Company’s Senior Vice President of Business Development and Product Definition since November 2019, overseeing business development of the Company’s business to business sales, technology licensing and strategic cooperation as well as leading its product strategy for future products, and has served as a member the Board from July 2021 to March 2023. Mr. Aydt has…read full bio


HORTON D R INC (DHI)
Leaving: CEO – David V Auld ( 9.0 yrs; 21.9% TSR)
Replaced by: Paul J Romanowski

Paul J. Romanowski Executive Vice President and Co-Chief Operating Officer Mr. Romanowski, age 52, is Executive Vice President and Co-Chief Operating Officer of D.R. Horton, positions he has held since October 1, 2021. Mr. Romanowski was Region President overseeing the Company’s homebuilding operations in Florida and the Gulf Coast from 2014 to 2021, and in 2019 his oversight responsibilities were…read full bio

PLANET FITNESS INC (PLNT)
Leaving: CEO – Christopher Rondeau ( 10.7 yrs; 17.8% TSR)
Replaced by: Craig R Benson

Benson, age 68, has served on the Board since July 2017. He currently serves as the Chief Executive Officer at Soft Draw Investments, LLC. Benson has also been a franchisee of Dunkin’ Donuts LLC for over 15 years with 147 stores. He previously served as the 79th Governor of the State of New Hampshire. During his tenure, the Cato Institute recognized Benson as the most effective new governor in the…read full bio

TINGO GROUP INC (TIO)
Leaving: CEO – Darren Mercer ( 3.4 yrs; 10.4% TSR)
Replaced by: Kenneth I Denos

Mr. Denos, age 55, has been a member of the Registrant’s Board since November 30, 2022. Mr. Denos served as Tingo’s Executive Vice President, General Counsel, and Corporate Secretary from September 2021 until December 1, 2022. Since June 2005, Mr. Denos has been an officer and director of Equus Total Return, Inc. (NYSE: EQS), a closed-end fund traded on the New York Stock Exchange, serving as its …read full bio

CFO Moves

3D SYSTEMS CORP (DDD)
Leaving: CFO – Michael Lynn Turner ( 1.2 yrs; -40.0% TSR)
Replaced by: Andrew Martin Johnson
 
Mr. Johnson, age 48, joined the Company in July 2006 and has since served in increasing roles of responsibility in the corporate and legal departments, including as Executive Vice President, Chief Legal Officer and Secretary since November 2014, Chief Corporate Development Officer since September 2022 and Interim Chief Executive Officer from October 2015 until April 2016. In addition to earning hi…read full bio

ALTI GLOBAL INC (ALTI)
Leaving: CFO – Reid Parmelee ( .3 yrs; )
Replaced by: Stephen D Yarad
 
Mr. Yarad joins AlTi from MFA Financial, Inc. (NYSE: MFA), a leading residential mortgage REIT, where he served as Chief Financial Officer and Treasurer since September of 2010. Prior to joining MFA, he was an audit partner in the New York financial services practice of KPMG LLP. Mr. read full bio

ATRECA INC (BCEL)
Leaving: CFO – Herb Cross ( 4.6 yrs; -60.3% TSR)
Replaced by: John A Orwin
 
John A. Orwin Mr. Orwin has served as our President and Chief Executive Officer and a member of our Board of Directors since April 2018. Prior to joining Atreca, from June 2013 through June 2017, Mr. Orwin served as Chief Executive Officer of Relypsa, Inc. and from June 2013 through March 2017 also served as President of Relypsa and served on its board of directors from June 2013 until Relypsa’s a…read full bio

BAUSCH HEALTH COMPANIES INC (BHC)
Leaving: CFO – Tom George Vadaketh ( 1.9 yrs; -45.7% TSR)
Replaced by: John S Barresi

 Mr. Barresi served as the Senior Vice President of Finance and Chief Accounting Officer of Bed Bath & Beyond, Inc. (“BBBY”). Prior to joining BBBY, Mr. Barresi served in various leadership roles at Tiffany & Co., including Vice Pre…read full bio

BRC INC (BRCC)
Leaving: CFO – Mark L Weinstein ( .1 yrs; )
Replaced by: Stephen M Kadenacy

Mr. Kadenacy, 55, previously served as the Company’s Chief Executive Officer from its formation in October 2021 until the closing of its business combination with SilverBox Engaged Merger Corp I (“SilverBox”), Authentic Brands LLC, and the other parties thereto in February 2022. Mr. Kadenacy also served as the chief executive officer of SilverBox from March 2021 until the closing of the business c…read full bio

ENVIRI CORP (NVRI)
Leaving: CFO – Pete Minan ( 1.2 yrs; 25.0% TSR)
Replaced by: Tom George Vadaketh

Mr. Vadaketh is a Chartered Accountant (ACA) from the Institute of Chartered Accountants in England and Wales and a Certified Public Accountant in the United States. He received an MBA from the University of Manchester (UK). In connection with his employment, Mr. Vadaketh will receive the following compensation: 1….read full bio

ENVISTA HOLDINGS CORP (NVST)
Leaving: CFO – Howard H Yu ( 4.3 yrs; 2.5% TSR)
Replaced by: Stephan Keller

Mr. Keller, age 49, has served as the Company’s Vice President, Investor Relations since March 2021. From July 2019 to March 2021, Mr. Keller served as the Company’s Vice President, Strategy and Business Development. From January 2016 to February 2019, Mr. Keller served as Vice President – Strategy & Corporate Development at Avery Dennison. He has a Bachelor of Science degree …read full bio

REPLIMUNE GROUP INC (REPL)
Leaving: CFO – Philip Astley-Sparke ( .3 yrs; )
Replaced by: Emily Luisa Hill
 
Ms. Hill, age 43, has served as Chief Financial Officer at PTC Therapeutics, Inc. since June 2019, and previously held various positions of increasing responsibility at PTC Therapeutics, Inc. since 2013. Previously, Ms. Hill was Director of Investor Relations at Warner Chilcott, Senior Manager of Investor Relations at Genzyme Corporation, and Biotech Equity Research Associate at Summer Street Part…read full bio

SOUTHERN MISSOURI BANCORP INC (SMBC)
Leaving: CFO – Matthew T Funke ( .1 yrs; 14.6% TSR)
Replaced by: Stefan Chkautovich

Mr. Chkautovich, age 38, joins the Company from Midwest Regional Bank, a bank headquartered in St. Louis, Missouri, with approximately $1.0 billion in assets, where he served as Chief Financial Officer since March 2022. Prior to joining Midwest Regional Bank, Mr. Chkautovich worked at K…read full bio

WARNER MUSIC GROUP CORP (WMG)
Leaving: CFO – Eric Levin ( 1.0 yrs; -11.3% TSR)
Replaced by: Bryan Castellani

Mr. Castellani, age 52, has been employed by The Walt Disney Company in various operational and financial roles since 1995. Most recently, he served as Executive Vice President and Chief Financial Officer, Disney Entertainment and ESPN, where he was responsible for leading business and financial planning functions for the Disney Media&…read full bio

 

Director Joins

ATRION CORP (ATRI)
Jeannette Bankes
Ms. Bankes brings to our Board over 32 years of experience at major medical device and pharmaceutical companies. Since March 2019, Ms. Bankes has served as the President and General Manager of the Global Surgical Franchise at Alcon Inc. From August 2004 to March 2019, Ms.&nb…read full bio

AZEK CO INC (AZEK)
Harmit J Singh
Harmit Singh (no relation to Jesse Singh, the Company’s Chief Executive Officer and President) currently serves as the Chief Financial and Growth Officer of Levi Strauss & Co. (NYSE: LEVI) where he is responsible for managing finance, strategy, information technology, strategic sourcing, real es…read full bio

AZEK CO INC (AZEK)
Pamela J Edwards
Pamela Edwards previously served as Executive Vice President and Chief Financial Officer of Citi Trends, Inc. (NASDAQ: CTRN) from January 2021 until April 2022. Prior to that, Ms. Edwards held various roles at L Brands Inc., one of the world’s leading specialty retailers, including as Chief Fi…read full bio

CARDLYTICS INC (CDLX)
Alex Mishurov
Alex Mishurov, age 48, has served as Chief Executive Officer and Chief Investment Officer of KPS Global Asset Management, a global alternative investment firm focused on public and private investments in robotics, technology, and e-commerce since 2017. Prior to founding KPS, Mr. Mishurov w…read full bio

CLENE INC (CLNN)
Matthew Kiernan
Professor Kiernan is the Bushell Chair of Neurology at the University of Sydney, and the Co-Director of the University’s Brain and Mind Centre. He is Professor of Neurology and Staff Specialist Neurologist at the Royal Prince Alfred Hospital, and is the incoming Chief Executive Offic…read full bio

COSMOS HEALTH INC (COSM)
Suhel Bhutawala
Mr. Bhutawala has a background in chemistry. Mr. Bhutawala has been a managing director of Decahedron Ltd in Harlow, U.K. since April 2017. From May 2015 to March 2017, he was commercial manager, in relation to procurements, sales and Private Investigator (PI) team assistance, at Chemilines Ltd in L…read full bio

FARADAY FUTURE INTELLIGENT ELECTRIC INC (FFIE)
Matthias Aydt
Mr. Aydt, age 66, has served as the Company’s Senior Vice President of Business Development and Product Definition since November 2019, overseeing business development of the Company’s business to business sales, technology licensing and strategic cooperation as well as leading its product strategy …read full bio

Green Thumb Industries Inc (GTBIF)
Hannah B. Ross
Ross is the Chief Operating Officer of Edie Parker, the leading female-founded lifestyle, fashion, and cannabis brand. She oversees the growth strategy and operations of the company, including direct management of the finance, sales, and marketing functions. Since 2018, Ross has also …read full bio

Green Thumb Industries Inc (GTBIF)
Richard Reisin
Reisin formerly served as Executive Vice President and Director at Carylon Corporation, a national organization of industry-leading, regional operating companies that offer a wide range of specialized services including sewer maintenance, industrial services, and water management for municipalities,…read full bio

LANCASTER COLONY CORP (LANC)
George F. Knight III
Mr. Knight spent 25 years with chemical company Hexion, Inc. and its predecessor company Borden, Inc., most recently serving as Hexion’s Executive Vice President and Chief Financial Officer. During his tenure at Hexion and Borden, he held roles of increasing responsibly including Vic…read full bio

LOEWS CORP (L)
Jonathan C Locker
Mr. Locker currently serves as President of Tiger Management, an investment firm founded by Julian H. Robertson, and previously served as a Partner at Tiger Global Management, an investment firm focused on public and private equity investments. In addition, since 2014 he has run a personal…read full bio

MONDEE HOLDINGS INC (MOND)
Jeffrey J Clarke
Currently, Clarke is serving as Interim CEO at Doxim, a customer communications management and engagement technology provider. In his career spanning over four decades, Clarke has held numerous C-suite roles within the technology, travel, and services industries, including leadin…read full bio

PINTEREST INC (PINS)
Scott F Schenkel
Scott spent 13 years at eBay, including serving as Interim Chief Executive Officer, following additional finance leadership roles such as Chief Financial Officer. Prior to eBay, Scott spent nearly two decades as Chief Financial Officer of multiple business lines at General Electric. H…read full bio

SNAP INC (SNAP)
Patrick Spence
Mr. Spence, age 49, has served as the Chief Executive Officer and member of the board of directors of Sonos, Inc. since January 2017, as its President since July 2016, and as its Chief Commercial Officer from June 2012 to June 2016. Prior to joining Sonos, Inc., Mr. Spence spent 14 ye…read full bio

SPORTSMAN’S WAREHOUSE HOLDINGS INC (SPWH)
Steven W. Sansom
Mr. Sansom, 54, has served as the founder and chairman of Steel Grove Capital Advisors and Steel Grove Family Office in Memphis, Tennessee since September 2001. Mr. Sansom was also a founder, principal and member of the board of directors of Center Coast Capital Advisors, an independent investor in …read full bio

STOKE THERAPEUTICS INC (STOK)
Ian F Smith
Ian F. Smith is a director of Stoke Therapeutics. He serves as a Senior Advisor to Bain Capital Life Sciences since January 2021. Mr. Smith also serves as Executive Chair of the Board of Directors of Solid Biosciences (Nasdaq: SLDB), as a director of Foghorn Therapeutics (Nasdaq: FHTX), Alkeus …read full bio

UGI CORP (UGI)
Santiago Seage
Mr. Seage has been serving as the Chief Executive Officer of Atlantica Sustainable Infrastructure plc (NASDAQ: AY), a sustainable infrastructure company that owns a diversified portfolio of renewable energy, storage, efficient natural gas, electric transmission and water assets in North and South Am…read full bio

VALLEY NATIONAL BANCORP (VLY)
Kathleen C. Perrott
Ms. Perrott served as Chief Audit Executive at Accenture LLP (“Accenture”), a global public professional services firm, from September 2014 to August 2020 and retired from the firm in February 2021. In her Chief Audit Executive role, Ms. Perrott led Accenture’s …read full bio

XENCOR INC (XNCR)
Barbara Klencke
Before joining Sierra Oncology in 2015, Dr. Klencke served as senior vice president of global development at Onyx Pharmaceuticals, where she led development and execution for Onyx’s pipeline programs, including the approval of Kyprolis® for multiple myeloma, through the company&r…read full bio

 

Director Leaves

AGBA GROUP HOLDING LTD (AGBA)
Suet Fai Almond Wong ( .8 yrs; -93.9% TSR)

BARNES & NOBLE EDUCATION INC (BNED)
Daniel A Dematteo ( 8.1 yrs; -25.7% TSR)
Committees: Audit, Compensation, Nominating (and Governance)

BARNES & NOBLE EDUCATION INC (BNED)
Emily C Chiu ( 5.3 yrs; -27.3% TSR)
Committees: Audit, Nominating (and Governance)

CATALYST PHARMACEUTICALS INC (CPRX)
Philip H Coelho ( 20.9 yrs; 4.9% TSR)
Committees: Audit, Nominating (and Governance)

CBOE GLOBAL MARKETS INC (CBOE)
Edward T Tilly ( 10.3 yrs; 16.3% TSR)
Committees: Executive

CLENE INC (CLNN)
John Henry Stevens ( 7.8 yrs; -42.0% TSR)


FARADAY FUTURE INTELLIGENT ELECTRIC INC (FFIE)
Xuefeng (“XF”) Chen ( 1.0 yrs; -94.8% TSR)


FEDEX CORP (FDX)
Kim Jabal ( 9.8 yrs; 8.0% TSR)
Committees: Audit, Audit and Finance, Cyber and Technology Oversight, Information Technology Oversight Committee

FLOWSERVE CORP (FLS)
John R Friedery ( 16.3 yrs; 4.7% TSR)
Committees: Audit, Compensation, Finance & Risk, Nominating (and Governance), Organization & Compensation

GAMING & LEISURE PROPERTIES INC (GLPI)
Joanne A Epps ( 2.0 yrs; 6.0% TSR)
Committees: Nominating (and Governance)

META MATERIALS INC (MMAT)
Eric M Leslie ( 2.3 yrs; -71.8% TSR)
Committees: Audit, Human Resources and Compensation

MICROMOBILITYCOM INC (MCOM)
Giulio Profumo ( 2.1 yrs; -98.3% TSR)

NEWELL BRANDS INC (NWL)
Gary Hu ( .3 yrs; )

NEWELL BRANDS INC (NWL)
David Willetts ( .5 yrs; -32.4% TSR)
Committees: Compensation and Human Capital, Nominating (and Governance)

NEWS CORP (NWSA)
Keith Rupert Murdoch ( 10.4 yrs; 4.0% TSR)


NORTHWEST BANCSHARES INC (NWBI)
William W Harvey ( 2.3 yrs; -9.6% TSR)


ONDAS HOLDINGS INC (ONDS)
Derek Reisfield ( 5.0 yrs; -43.5% TSR)
Committees: Audit, Compensation, Nominating (and Governance)

PARATEK PHARMACEUTICALS INC (PRTK)
Michael Bigham ( 8.9 yrs; -20.8% TSR)


PARATEK PHARMACEUTICALS INC (PRTK)
Evan Loh ( 8.9 yrs; -20.8% TSR)


PARATEK PHARMACEUTICALS INC (PRTK)
Jeffrey Stein ( 8.9 yrs; -20.8% TSR)
Committees: Audit, Compensation

PARATEK PHARMACEUTICALS INC (PRTK)
Kristine Peterson ( 7.5 yrs; -21.6% TSR)
Committees: Audit, Nominating (and Governance)

PARATEK PHARMACEUTICALS INC (PRTK)
Minnie Baylor-Henry ( 2.3 yrs; -41.6% TSR)
Committees: Audit

PARATEK PHARMACEUTICALS INC (PRTK)
Robert S Radie ( 8.9 yrs; -20.8% TSR)
Committees: Audit, Compensation, Nominating (and Governance)

PARATEK PHARMACEUTICALS INC (PRTK)
Rolf K Hoffmann ( 5.4 yrs; -28.3% TSR)
Committees: Nominating (and Governance)

PARATEK PHARMACEUTICALS INC (PRTK)
Thomas John Dietz ( 10.4 yrs; -21.4% TSR)
Committees: Audit, Compensation

PARATEK PHARMACEUTICALS INC (PRTK)
Timothy R Franson ( 8.2 yrs; -26.5% TSR)
Committees: Compensation, Nominating (and Governance)

RADIUS GLOBAL INFRASTRUCTURE INC (RADI)
William D Rahm ( 3.6 yrs; 23.6% TSR)


RADIUS GLOBAL INFRASTRUCTURE INC (RADI)
William H Berkman ( 3.6 yrs; 23.6% TSR)


RADIUS GLOBAL INFRASTRUCTURE INC (RADI)
Michael D Fascitelli ( 5.8 yrs; 23.6% TSR)


RADIUS GLOBAL INFRASTRUCTURE INC (RADI)
Thomas C King ( 3.6 yrs; 23.6% TSR)


RADIUS GLOBAL INFRASTRUCTURE INC (RADI)
Antoinette Cook Bush ( 3.6 yrs; 23.6% TSR)


RADIUS GLOBAL INFRASTRUCTURE INC (RADI)
Ashley Leeds ( 2.8 yrs; 23.6% TSR)


RADIUS GLOBAL INFRASTRUCTURE INC (RADI)
Noam Gottesman ( 5.8 yrs; 23.6% TSR)


RADIUS GLOBAL INFRASTRUCTURE INC (RADI)
Paul A Gould ( 3.6 yrs; 23.6% TSR)


RADIUS GLOBAL INFRASTRUCTURE INC (RADI)
Nick S Advani ( 3.6 yrs; 23.6% TSR)


TINGO GROUP INC (TIO)
Robert John Benton ( 2.4 yrs; -21.9% TSR)
Committees: Audit, Compensation, Nominating (and Governance)

 

 

Recent Analysis

Daily SPAC Update – May 24, 2024

QRDO To Liquidate at $10.96. ShoulderUp Extends with 1.1M Redemptions. BFAC Extension Vote. Churchill Investor Deck. DIST Merger Agreement.

Daily SPAC Update – May 23, 2024

MAQC + Immersed Inc. Deal Terminated. GPAC Deal Vote Set. IVCB Extends w/ 2.1M Redemptions. CVII Investor Deck. PWUP Redemption Agreement.

Subscribe to Boardroom Alpha Newsletters

Subscribe to Boardroom Alpha's research to receive the latest on governance, SPACs, and people.

Disclaimer

The opinions and information contained herein have been obtained or derived from sources believed to be reliable, but Boardroom Alpha cannot guarantee its accuracy and completeness, and that of the opinions based thereon. 

This report contains opinions and is provided for informational purposes only – it does not constitute investment, legal or tax advice. You should not rely solely upon the research herein for purposes of transacting securities or other investments, and you are encouraged to conduct your own research and due diligence, and to seek the advice of a qualified securities professional before you make any investment.  

None of the information contained in this report constitutes, or is intended to constitute a recommendation by Boardroom Alpha of any particular security or trading strategy or a determination by BA that any security or trading strategy is suitable for any specific person. To the extent any of the information contained herein may be deemed to be investment advice, such information is impersonal and not tailored to the investment needs of any specific person.  

No representation or warranty, expressed or implied, is made on behalf of Boardroom Alpha as to the accuracy or completeness of the information contained herein. Boardroom Alpha does not accept any liability for any direct, indirect or consequential loss or damage suffered by any person as a result of relying on all or any part of this research and any liability is expressly disclaimed.